リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「In vitro selection and studies on tRNA-recognizing ribozymes derived from T-box motifs」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

In vitro selection and studies on tRNA-recognizing ribozymes derived from T-box motifs

石田, 啓 東京大学 DOI:10.15083/0002004742

2022.06.22

概要

Introduction
 In the current world, life is governed by three types of biomolecules; DNA, RNA and protein. Genetic information is stored in the form of DNA which is transcribed into mRNA and then translated into protein and all of these processes are done with the help of protein enzymes. Before the emergence of such complicated biological system, it is proposed that early life form could have been relying on RNA based system where RNA was responsible for both genomic storage and chemical reaction catalysis. This hypothesis is called the RNA world hypothesis which is one of the most popular hypotheses of life on early earth. The plausibility of this hypothesis was enhanced by the discovery of catalytic RNAs such as RNase P or self-splicing RNA in nature or the obtainment of artificial ribozymes with the use of SELEX (Systematic Evolution of Ligands by EXponential enrichment). Aminoacylation ribozymes are particular of interest since they provide the bridge between RNA world and the modern DNA/RNA/protein world. Several aminoacylation ribozymes have been developed in the lab but their sequences were not related to the currently existing RNA molecular fossils, i.e. not to be a part of reminiscence of the RNA world.
 In this study I have aimed at discovering aminoacylation ribozymes from a library consisting of a small random sequence domain embedded in a molecular fossil of the RNA world found in contemporary life. To accomplish this, I have focused on a specific riboswitch called the T-box riboswitch given that some modern riboswitches are considered the biological fossils of ancient ribozymes existed in the RNA world.

In vitro selection of aminoacylation ribozyme using T-box motif
 T-box riboswitch is an RNA motif that is found in gram-positive bacteria. It resides in the upstream of the gene it regulates, and monitors amino acid status by monitoring the aminoacylation status of the cognate tRNA. When a specific tRNA is charged with the cor-responding amino acid, there is no change in the T-box riboswitch structure. However, when a specific uncharged tRNA is present, T-box binds with this tRNA, undergoes a structural change and starts the transcription of the downstream gene. I focused on this tRNA recognition property of T-box riboswitch and randomized a portion of T-box riboswitch in the hope of given additional aminoacylation activity. In vitro selection was conducted to fish out the desired species from the partially randomized T- box library. Bio-L-Phe-CME was used as the amino acid substrate and active species were selectively recovered through streptavidin coated magnetic beads. Through 7 rounds of screening process, enrichment of active species was observed and ribozyme named Tx2.1 was identified which has both self-aminoacylation (in cis) and transaminoacylation activity. Further characterization of Tx2.1 revealed that this ribozyme was specific to bio-L-Phe-CME suggesting that this ribozyme recognizes both the biotin residue and the side chain residue (Figure 1a). The natural T-box forms base-paring with the tRNA anticodon and this property was maintained for Tx2.1. This ribozyme recognizes the tRNA anticodon and the activity is abolished when tRNA bearing anticodon that forms no-base paring was treated with Tx2.1 (Figure 1b). The lost activity was recovered when compensatory mutastion was introduced to the Tx2.1 specifier sequence. Not only the anticodon interaction but tRNA D-loop interaction with the T-box apical loop was also observed for natural T-box and similar interaction could be observed by monitoring the aminoacylation yield of tRNA mutants with different D-loop size (Figure 1c). The larger the loop size was, the less the aminoacylation activity became. The secondary structure of Tx2.1 was validated by deep mutational scanning of the Tx2.1 random domain. Figure 2a shows the heat map representing the effect of each mutation to the aminoacylation activity. This heat map along with other aminoacylation activity measurement toward Tx2.1 mutant revealed the most plausible secondary structure of Tx2.1 (Figure 2b).
 With the tRNA recognizing aminoacylation ribozyme in hand, I also checked whether aminoacylation by Tx2.1 can function in parallel with translation. The expression of a model peptide was evaluated in the presence of Tx2.1, tRNAGly , Bio-L-Phe-CME, and a DNA template within our FIT (Flexible In-vitro Translation) cock-tail. If Tx2.1 can aminoacylate tRNAGly using Bio-L-Phe- CME in the FIT cocktail, a model peptide initiating with Bio-L-Phe should be observed. Since Tx2.1 was most active toward tRNA bearing GCC anticodon, the start codon was engineered to GGC rather than the canonical AUG to initiate the translation with Bio- L-Phe (Figure 3a). The expression of model peptide was measured by Tricine SDS-PAGE and a clear band corresponding to the full-length product was observed only when all of the Tx2.1 aminoacylation component was added to the translation mixture. The identity of the band was confirmed by MALDI-TOF MS showing the correct mass corresponding to the Bio-L-Phe initiated peptide. These results indicate that Tx2.1 indeed function within the translation mixture and the aminoacyl-tRNA produced was accepted by ribosome for translation.
 Since Tx2.1 was specific for Bio-L-Phe-CME, I have also attempted to change the specificity of the aminoacylation ribozyme. Conducting the same in vitro selection using the partially randomized T-box riboswitch with different amino acids, I also succeeded in obtaining aminoacylation ribozymes which accept amino acid substrate having biotin residue on the side chain or biotinylation ribozymes.

Conclusion
 Using T-box sequence as the starting structure, I have succeeded in discovering aminoacylation ribozymes that function either in cis or also in trans. The trans acting ribozyme Tx2.1 inherited the tRNA specificity nature and also possessed amino acid specificity which is a similar function to the protein aminoacyl-tRNA syntheatse. I also succeeded in coupling aminoacylation ribozyme Tx2.1 with the in vitro translation mixture demonstrating for the first time that aminoacylation ribozyme can function within the translation machinery. This discovery of aminoacylation ribozyme from possible relic of RNA world presents us the link between RNA world and the protein world governed by the genetic code.

参考文献

1. Kumar, R. & Yarus, M. RNA-catalyzed amino acid activation. Biochemistry 40, 6998-7004 (2001).

2. Illangasekare, M., Sanchez, G., Nickles, T. & Yarus, M. Aminoacyl-RNA synthesis catalyzed by an RNA. Science 267, 643-647 (1995).

3. Walter, G. Origin of life: The RNA world. Nature 319(1986).

4. Kruger, K. et al. Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena. Cell 31, 147-157 (1982).

5. Guerrier-Takada, C., Gardiner, K., Marsh, T., Pace, N. & Altman, S. The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35, 849-857 (1983).

6. Tuerk, C. & Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510 (1990).

7. Ellington, A. & Szostak, J. In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822 (1990).

8. Nissen, P., Hansen, J., Ban, N., Moore, P.B. & Steitz, T.A. The structural basis of ribosome activity in peptide bond synthesis. Science 289, 920-930 (2000).

9. Moore, P.B. & Steitz, T.A. The structural basis of large ribosomal subunit function. Annu. Rev. Biochem. 72, 813-850 (2003).

10. Crick, F.H. The origin of the genetic code. J. Mol. Biol. 38, 367-379 (1968).

11. Johnston, W.K., Unrau, P.J., Lawrence, M.S., Glasner, M.E. & Bartel, D.P. RNA-catalyzed RNA polymerization: accurate and general RNA-templated primer extension. Science 292, 1319-1325 (2001).

12. McDaniel, B.A., Grundy, F.J., Artsimovitch, I. & Henkin, T.M. Transcription termination control of the S box system: direct measurement of S-adenosylmethionine by the leader RNA. Proc. Natl. Acad. Sci. U. S. A. 100, 3083-3088 (2003).

13. Fuchs, R.T., Grundy, F.J. & Henkin, T.M. The S(MK) box is a new SAM-binding RNA for translational regulation of SAM synthetase. Nat. Struct. Mol. Biol. 13, 226-233 (2006).

14. Nahvi, A. et al. Genetic control by a metabolite binding mRNA. Chem. Biol. 9, 1043 (2002).

15. Mironov, A.S. et al. Sensing small molecules by nascent RNA: a mechanism to control transcription in bacteria. Cell 111, 747-756 (2002).

16. Mandal, M. & Breaker, R.R. Adenine riboswitches and gene activation by disruption of a transcription terminator. Nat. Struct. Mol. Biol. 11, 29-35 (2004).

17. Mandal, M., Boese, B., Barrick, J.E., Winkler, W.C. & Breaker, R.R. Riboswitches control fundamental biochemical pathways in Bacillus subtilis and other bacteria. Cell 113, 577-586 (2003).

18. Watson, P.Y. & Fedor, M.J. The ydaO motif is an ATP-sensing riboswitch in Bacillus subtilis. Nat. Chem. Biol. 8, 963-965 (2012).

19. Kim, J.N., Roth, A. & Breaker, R.R. Guanine riboswitch variants from Mesoplasma florum selectively recognize 2'-deoxyguanosine. Proc. Natl. Acad. Sci. U. S. A. 104, 16092-16097 (2007).

20. Mandal, M. et al. A glycine-dependent riboswitch that uses cooperative binding to control gene expression. Science 306, 275-279 (2004).

21. Grundy, F.J., Lehman, S.C. & Henkin, T.M. The L box regulon: lysine sensing by leader RNAs of bacterial lysine biosynthesis genes. Proc. Natl. Acad. Sci. U. S. A. 100, 12057-12062 (2003).

22. Ames, T.D. & Breaker, R.R. Bacterial aptamers that selectively bind glutamine. RNA Biol. 8, 82- 89 (2011).

23. Winkler, W.C., Nahvi, A., Roth, A., Collins, J.A. & Breaker, R.R. Control of gene expression by a natural metabolite-responsive ribozyme. Nature 428, 281-286 (2004).

24. Furukawa, K. et al. Bacterial riboswitches cooperatively bind Ni(2+) or Co(2+) ions and control expression of heavy metal transporters. Mol. Cell 57, 1088-1098 (2015).

25. Cromie, M.J., Shi, Y., Latifi, T. & Groisman, E.A. An RNA sensor for intracellular Mg(2+). Cell 125, 71-84 (2006).

26. Baker, J.L. et al. Widespread genetic switches and toxicity resistance proteins for fluoride. Science 335, 233-235 (2012).

27. Grundy, F.J., Rollins, S.M. & Henkin, T.M. Interaction between the acceptor end of tRNA and the T box stimulates antitermination in the Bacillus subtilis tyrS gene: a new role for the discriminator base. J. Bacteriol. 176, 4518-4526 (1994).

28. Saad, N.Y. et al. Two-codon T-box riboswitch binding two tRNAs. Proc. Natl. Acad. Sci. U. S. A. 110, 12756-12761 (2013).

29. Sherwood, A.V., Grundy, F.J. & Henkin, T.M. T box riboswitches in Actinobacteria: translational regulation via novel tRNA interactions. Proc. Natl. Acad. Sci. U. S. A. 112, 1113-1118 (2015).

30. Breaker, R.R. Riboswitches and the RNA World. Cold Spring Harb. Perspect. Biol. 4(2012).

31. Tuerk, C. & Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510 (1990).

32. Wochner, A., Attwater, J., Coulson, A. & Holliger, P. Ribozyme-catalyzed transcription of an active ribozyme. Science 332, 209-212 (2011).

33. Sczepanski, J.T. & Joyce, G.F. A cross-chiral RNA polymerase ribozyme. Nature 515, 440-442 (2014).

34. Tsukiji, S., Pattnaik, S.B. & Suga, H. An alcohol dehydrogenase ribozyme. Nat. Struct. Biol. 10, 713-717 (2003).

35. Seelig, B. & Jäschke, A. A small catalytic RNA motif with Diels-Alderase activity. Chem. Biol. 6, 167-176 (1999).

36. Agresti, J.J., Kelly, B.T., Jäschke, A. & Griffiths, A.D. Selection of ribozymes that catalyse multiple-turnover Diels-Alder cycloadditions by using in vitro compartmentalization. Proc. Natl. Acad. Sci. U. S. A. 102, 16170-16175 (2005).

37. Lee, N., Bessho, Y., Wei, K., Szostak, J. & Suga, H. Ribozyme-catalyzed tRNA aminoacylation. Nat. Struct. Biol. 7, 28-33 (2000).

38. Saito, H., Kourouklis, D. & Suga, H. An in vitro evolved precursor tRNA with aminoacylation activity. EMBO J. 20, 1797-1806 (2001).

39. Illangasekare, M. & Yarus, M. Specific, rapid synthesis of Phe-RNA by RNA. Proc. Natl. Acad. Sci. U. S. A. 96, 5470-5475 (1999).

40. Murakami, H., Ohta, A., Ashigai, H. & Suga, H. A highly flexible tRNA acylation method for non-natural polypeptide synthesis. Nat. Methods 3, 357-359 (2006).

41. Chumachenko, N., Novikov, Y. & Yarus, M. Rapid and simple ribozymic aminoacylation using three conserved nucleotides. J. Am. Chem. Soc. 131, 5257-5263 (2009).

42. Lohse, P.A. & Szostak, J.W. Ribozyme-catalysed amino-acid transfer reactions. Nature 381, 442- 444 (1996).

43. Suga, H., Lohse, P.A. & Szostak, J.W. Structural and kinetic characterization of an acyl transferase ribozyme. J. Am. Chem. Soc. 120, 1151-1156 (1998).

44. Bessho, Y., Hodgson, D.R.W. & Suga, H. A tRNA aminoacylation system for non-natural amino acids based on a programmable ribozyme. Nat. Biotechnol. 20, 723-728 (2002).

45. Murakami, H., Saito, H. & Suga, H. A versatile tRNA aminoacylation catalyst based on RNA. Chem. Biol. 10, 655-662 (2003).

46. Niwa, N., Yamagishi, Y., Murakami, H. & Suga, H. A flexizyme that selectively charges amino acids activated by a water-friendly leaving group. Bioorg. Med. Chem. Lett. 19, 3892-3894 (2009).

47. Ohta, A., Murakami, H., Higashimura, E. & Suga, H. Synthesis of polyester by means of genetic code reprogramming. Chem. Biol. 14, 1315-1322 (2007).

48. Goto, Y. et al. Reprogramming the translation initiation for the synthesis of physiologically stable cyclic peptides. ACS Chem. Biol. 3, 120-129 (2008).

49. Kawakami, T. et al. Diverse backbone-cyclized peptides via codon reprogramming. Nat. Chem. Biol. 5, 888-890 (2009).

50. Kawakami, T., Murakami, H. & Suga, H. Messenger RNA-programmed incorporation of multiple N-methyl-amino acids into linear and cyclic peptides. Chem. Biol. 15, 32-42 (2008).

51. Yamagishi, Y. et al. Natural product-like macrocyclic N-methyl-peptide inhibitors against a ubiquitin ligase uncovered from a ribosome-expressed de novo library. Chem. Biol. 18, 1562-1570 (2011).

52. Hayashi, Y., Morimoto, J. & Suga, H. In vitro selection of anti-Akt2 thioether-macrocyclic peptides leading to isoform-selective inhibitors. ACS Chem. Biol. 7, 607-613 (2012).

53. Morimoto, J., Hayashi, Y. & Suga, H. Discovery of macrocyclic peptides armed with a mechanism-based warhead: isoform-selective inhibition of human deacetylase SIRT2. Angew. Chem. Int. Ed. Engl. 51, 3423-3427 (2012).

54. Tanaka, Y. et al. Structural basis for the drug extrusion mechanism by a MATE multidrug transporter. Nature 496, 247-251 (2013).

55. Ito, K. et al. Artificial human Met agonists based on macrocycle scaffolds. Nat. Commun. 6, 6373 (2015).

56. Matsunaga, Y., Bashiruddin, N.K., Kitago, Y., Takagi, J. & Suga, H. Allosteric Inhibition of a Semaphorin 4D Receptor Plexin B1 by a High-Affinity Macrocyclic Peptide. Cell Chem Biol 23, 1341-1350 (2016).

57. Jongkees, S.A.K. et al. Rapid Discovery of Potent and Selective Glycosidase-Inhibiting De Novo Peptides. Cell Chem Biol 24, 381-390 (2017).

58. Kawamura, A. et al. Highly selective inhibition of histone demethylases by de novo macrocyclic peptides. Nat. Commun. 8, 14773 (2017).

59. Yu, H. et al. Macrocycle peptides delineate locked-open inhibition mechanism for microorganism phosphoglycerate mutases. Nat. Commun. 8, 14932 (2017).

参考文献をもっと見る